Scientific Sessions 2025  /  Transformative Advances in Genome Engineering for Precision Therapy  /  Treating cardiovascular disease with Base and Prime Editing
Logo

American Heart Association

  45
  0

Final ID:

Treating cardiovascular disease with Base and Prime Editing

  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
  • Steinmetz, Lars  ( Stanford University , LA , California , United States )
  • Olson, Eric  ( UNIV TEXAS SOUTHWESTERN MED CTR , Dallas , Texas , United States )
    • Author Disclosures:
    Christine Seidman: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Merck, Board of Directors:Active (exists now) ; Advisor:Tenaya:Active (exists now) ; Advisor:Maze:Past (completed) | Lars Steinmetz: DO have relevant financial relationships ; Consultant:Sophia Genetics:Active (exists now) ; Consultant:Levitas Bio:Active (exists now) | Eric Olson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Developing single course in vivo gene editing therapies for hyperlipidemia

Kathiresan Sekar, Musunuru Kiran, Ishikawa Kiyotake

Development and evolution of novel genome engineering technologies

Newby Gregory, Gaudelli Nicole, Liu David

More abstracts from these authors:
Gene Therapy: The Next Frontier or Fool's Gold?

Seidman Christine, Watkins Hugh

So How Do We Determine the Right Strategy for the Right Patient?

Watkins Hugh, Seidman Christine

You have to be authorized to contact abstract author. Please, Login
Not Available